Tripeptide-10 Citrulline vs Oligopeptide-1
Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research
Also: Decorinyl, Decorin-like tetrapeptide
Tripeptide-10 citrulline, sold as Decorinyl, is a small synthetic peptide (four residues, despite the name) designed by the Spanish ingredient maker Lipotec to mimic decorin, a protein that keeps collagen fibers neat and evenly sized. The pitch is better collagen, not more collagen. It is a cosmetic ingredient, not an FDA-approved drug, and almost all of the evidence comes from the company that makes it.
Also: sh-Oligopeptide-1, rh-Oligopeptide-1
sh-Oligopeptide-1 is the cosmetic ingredient name for recombinant human epidermal growth factor (EGF), a 53-amino-acid protein your skin uses to tell cells to divide and repair. It shows up in 'EGF serums' aimed at wrinkles, texture and post-procedure recovery. It is a cosmetic ingredient in skincare, not an FDA-approved drug for skin aging, and while there are a fair number of small human studies, very few are properly controlled.
Key Comparison Insights
- Both peptides belong to the Skin & Hair category, suggesting similar primary applications.
- Oligopeptide-1 has stronger research evidence (Human Trials) compared to Tripeptide-10 Citrulline (Limited Research).
Detailed Comparison
| Attribute | Tripeptide-10 Citrulline | Oligopeptide-1 |
|---|---|---|
| Category | Skin & Hair | Skin & Hair |
| FDA Status | Not FDA Approved | Not FDA Approved |
| Clinical Status | Pre I II III IV FDA | Pre I II III IV FDA |
| Mechanism of Action | Decorin sits on collagen fibrils and controls how thick they grow and how tightly they pack. With age, decorin activity drops, and collagen fibers become uneven and disorganized, which is part of why older skin loses suppleness. Lipotec researchers took the two short sequences decorin uses to grab collagen, built a library of tetrapeptides around them, and screened them in a test-tube collagen assembly assay. The winner, tripeptide-10 citrulline, made fibrils thinner and more uniform in that assay. The idea is that a well-organized collagen network is more cohesive and supple. Whether a topical cream delivers enough peptide to the dermis to do this in real skin has not been independently shown. | EGF binds the EGF receptor on keratinocytes and fibroblasts and switches on growth and repair signaling: cell division, migration, and production of matrix proteins. That is why it has been studied for wound healing, and why cosmetic brands use it to support skin renewal. Two practical problems: EGF is a fairly large protein, so getting it through intact skin is hard (which is why many studies pair it with microneedling or lasers), and it is fragile, so how much stays active in a jar at room temperature is a fair question. The same growth-promoting signal is also the source of the safety debate: EGF receptor signaling drives several cancers, so the concern is not that EGF causes cancer, but whether it could encourage abnormal cells that are already there. |
| Common Dosing | Around 0.01% peptide in a finished product Once or twice daily | Low parts-per-million concentration in a serum Once or twice daily |
| Administration | Topical (serums, creams) | Topical (serums, ampoules, creams); sometimes combined with microneedling in clinic |
| Typical Duration | Studies ran 2 months (60 days); ongoing use for maintained effects | Studies typically ran 4 to 12 weeks |
| Best Time to Take | Morning and/or evening skincare routine | Evening skincare routine, or right after an in-clinic procedure |
Possible Side Effects May vary by individual |
|
|
| Research Summary | The founding paper is Puig, Garcia Anton and Mangues (Lipotec) in the Journal of Cosmetic Science, 2008, which describes the in vitro fibrillogenesis screen. Trade press reporting of the same company work described a 0.01 percent formula applied for two months that made collagen fibers more uniform in a handful of volunteers, and a placebo comparison (22 women on peptide, 21 on placebo) reporting a 54 percent rise in suppleness. Those numbers come from the manufacturer and are not easy to check against full published data. The one independent-looking human trial is Raikou and colleagues, Journal of Cosmetic Dermatology 2017: 24 volunteers split into four groups (combination with acetyl hexapeptide-3, each peptide alone, or neither) for 60 days, with some statistically significant differences in wrinkle microtopography and water loss. Six people per group is very small, and the authors themselves could not explain any synergy. Fair summary: a clever design with real in vitro logic, and thin human data. | A 2021 systematic review in the Journal of Cutaneous and Aesthetic Surgery (Miller-Kobisher and colleagues) found 49 articles on rhEGF for skin, including 23 aesthetic studies. Most reported less wrinkling, better hydration and elasticity, and the strongest data were for pigmentation after lasers and melasma. But the authors admit many trials were uncontrolled or not randomized, samples were often 8 to 40 people, and they called for proper controlled trials. Adverse effects were mild and short-lived. The review did not address cancer risk at all, which is a real gap. Several of the better-known growth-factor trials tested multi-factor mixtures, not EGF alone. On safety: there is no human evidence that cosmetic EGF causes skin cancer, and in vitro tests of growth-factor cosmetics on melanoma cells were reassuring, but long-term studies in healthy skin do not exist. Sensible caution: people with a history of skin cancer, many atypical moles, or active psoriasis should talk to a dermatologist before using it. Bottom line: plausible and widely used, modest and mostly low-quality efficacy data, and an unresolved theoretical safety question. |
Frequently Asked Questions: Tripeptide-10 Citrulline vs Oligopeptide-1
What is the difference between Tripeptide-10 Citrulline and Oligopeptide-1?
Tripeptide-10 Citrulline is a skin & hair peptide that tripeptide-10 citrulline, sold as decorinyl, is a small synthetic peptide (four residues, despite the name) designed by the spanish ingredient maker lipotec to mimic decorin, a protein that keeps collagen fibers neat and evenly sized. the pitch is better collagen, not more collagen. it is a cosmetic ingredient, not an fda-approved drug, and almost all of the evidence comes from the company that makes it. Oligopeptide-1 is a skin & hair peptide that sh-oligopeptide-1 is the cosmetic ingredient name for recombinant human epidermal growth factor (egf), a 53-amino-acid protein your skin uses to tell cells to divide and repair. it shows up in 'egf serums' aimed at wrinkles, texture and post-procedure recovery. it is a cosmetic ingredient in skincare, not an fda-approved drug for skin aging, and while there are a fair number of small human studies, very few are properly controlled. The main differences lie in their mechanisms of action and clinical applications.
Which is better, Tripeptide-10 Citrulline or Oligopeptide-1?
Neither is universally "better" - the choice depends on your specific goals. Tripeptide-10 Citrulline is typically used for skin & hair purposes, while Oligopeptide-1 is used for skin & hair. Always consult with a healthcare provider to determine which may be appropriate for your situation.
Can Tripeptide-10 Citrulline and Oligopeptide-1 be used together?
Some peptide protocols combine multiple compounds for synergistic effects. However, using Tripeptide-10 Citrulline and Oligopeptide-1 together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.